UNSPSC 51381602: Parcetasal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H15NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3LSZ7869T2, chemically known as acetamide, n-(4-((2-methyl-4-oxo-4h-1,3-benzadioxin-2-yl)oxy)-phenyl)- but generally known as parcetasal, which bears US NIH Compound Identifier 65656. European Medicines Agency schedules Parcetasal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09621MIG.

UNSPSC 51381602 Parcetasal is a Commodity code that does not map to the work state and local governments are actually soliciting under it in recent opportunities. The three most recent postings for this code involve DeZurik/APCO valve components and repair services for wastewater treatment (Broward County, Florida), parenteral nutrition and intravenous solutions for correctional healthcare (Washington State Department of Corrections), and sodium bisulfite chemical supply for municipal water treatment (City of Meriden, Connecticut). None of these solicitations involve parcetasal or acetaminophen products. The code appears to be a pharmaceutical commodity designation that does not align with current state and local procurement activity in this dataset.

The mismatch between the code's nominal scope and actual solicitation content suggests either a tagging error in the state and local procurement system or that parcetasal is not a commodity state and local agencies are actively sourcing at this time. The issuing bodies span different sectors — a county public works operation, a state correctional system, and a municipal utility — but their actual needs fall outside pharmaceutical procurement. No relevant recent opportunities exist for parcetasal under this UNSPSC code.